ArticleAvicenna journal of medical biotechnology

Immunogenic Consideration of a Designed Polypeptide Against Brucellosis Compared to RB51: An

Mina Saadat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.